China Antisense and RNAi Therapeutics Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Antisense and RNAi Therapeutics Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Antisense and RNAi Therapeutics Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Antisense and RNAi Therapeutics Overall Market Size
2.1 China Antisense and RNAi Therapeutics Market Size: 2021 VS 2027
2.2 China Antisense and RNAi Therapeutics Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antisense and RNAi Therapeutics Players in China Market
3.2 Top China Antisense and RNAi Therapeutics Companies Ranked by Revenue
3.3 China Antisense and RNAi Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Antisense and RNAi Therapeutics Companies in China Market, by Revenue in 2020
3.5 Companies Antisense and RNAi Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antisense and RNAi Therapeutics Players in China Market
3.6.1 List of Tier 1 Antisense and RNAi Therapeutics Companies in China
3.6.2 List of Tier 2 and Tier 3 Antisense and RNAi Therapeutics Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Antisense and RNAi Therapeutics Market Size Markets, 2021 & 2027
4.1.2 RNA Interference
4.1.3 Antisense RNA
4.2 By Type - China Antisense and RNAi Therapeutics Revenue & Forecasts
4.2.1 By Type - China Antisense and RNAi Therapeutics Revenue, 2016-2021
4.2.2 By Type - China Antisense and RNAi Therapeutics Revenue, 2022-2027
4.2.3 By Type - China Antisense and RNAi Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Antisense and RNAi Therapeutics Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - China Antisense and RNAi Therapeutics Revenue & Forecasts
5.2.1 By Application - China Antisense and RNAi Therapeutics Revenue, 2016-2021
5.2.2 By Application - China Antisense and RNAi Therapeutics Revenue, 2022-2027
5.2.3 By Application - China Antisense and RNAi Therapeutics Revenue Market Share, 2016-2027
6 Antisense and RNAi Therapeutics Companies Profiles
6.1 Tekmira Pharmaceuticals
6.1.1 Tekmira Pharmaceuticals Company Details
6.1.2 Tekmira Pharmaceuticals Business Overview
6.1.3 Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Introduction
6.1.4 Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Revenue in China Market (2016-2021)
6.1.5 Tekmira Pharmaceuticals Recent Developments
6.2 Arbutus Biopharma
6.2.1 Arbutus Biopharma Company Details
6.2.2 Arbutus Biopharma Business Overview
6.2.3 Arbutus Biopharma Antisense and RNAi Therapeutics Introduction
6.2.4 Arbutus Biopharma Antisense and RNAi Therapeutics Revenue in China Market (2016-2021)
6.2.5 Arbutus Biopharma Recent Developments
6.3 Alnylam Pharmaceuticals
6.3.1 Alnylam Pharmaceuticals Company Details
6.3.2 Alnylam Pharmaceuticals Business Overview
6.3.3 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Introduction
6.3.4 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Revenue in China Market (2016-2021)
6.3.5 Alnylam Pharmaceuticals Recent Developments
6.4 Antisense Therapeutics
6.4.1 Antisense Therapeutics Company Details
6.4.2 Antisense Therapeutics Business Overview
6.4.3 Antisense Therapeutics Antisense and RNAi Therapeutics Introduction
6.4.4 Antisense Therapeutics Antisense and RNAi Therapeutics Revenue in China Market (2016-2021)
6.4.5 Antisense Therapeutics Recent Developments
6.5 Silence Therapeutics
6.5.1 Silence Therapeutics Company Details
6.5.2 Silence Therapeutics Business Overview
6.5.3 Silence Therapeutics Antisense and RNAi Therapeutics Introduction
6.5.4 Silence Therapeutics Antisense and RNAi Therapeutics Revenue in China Market (2016-2021)
6.5.5 Silence Therapeutics Recent Developments
6.6 Isis Pharmaceuticals
6.6.1 Isis Pharmaceuticals Company Details
6.6.2 Isis Pharmaceuticals Business Overview
6.6.3 Isis Pharmaceuticals Antisense and RNAi Therapeutics Introduction
6.6.4 Isis Pharmaceuticals Antisense and RNAi Therapeutics Revenue in China Market (2016-2021)
6.6.5 Isis Pharmaceuticals Recent Developments
6.7 Sirnaomics
6.7.1 Sirnaomics Company Details
6.7.2 Sirnaomics Business Overview
6.7.3 Sirnaomics Antisense and RNAi Therapeutics Introduction
6.7.4 Sirnaomics Antisense and RNAi Therapeutics Revenue in China Market (2016-2021)
6.7.5 Sirnaomics Recent Developments
6.8 Santaris
6.8.1 Santaris Company Details
6.8.2 Santaris Business Overview
6.8.3 Santaris Antisense and RNAi Therapeutics Introduction
6.8.4 Santaris Antisense and RNAi Therapeutics Revenue in China Market (2016-2021)
6.8.5 Santaris Recent Developments
6.9 Roche
6.9.1 Roche Company Details
6.9.2 Roche Business Overview
6.9.3 Roche Antisense and RNAi Therapeutics Introduction
6.9.4 Roche Antisense and RNAi Therapeutics Revenue in China Market (2016-2021)
6.9.5 Roche Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of TablesTable 1. Antisense and RNAi Therapeutics Market Opportunities & Trends in China Market
Table 2. Antisense and RNAi Therapeutics Market Drivers in China Market
Table 3. Antisense and RNAi Therapeutics Market Restraints in China Market
Table 4. Key Players of Antisense and RNAi Therapeutics in China Market
Table 5. Top Antisense and RNAi Therapeutics Players in China Market, Ranking by Revenue (2019)
Table 6. China Antisense and RNAi Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Antisense and RNAi Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Companies Antisense and RNAi Therapeutics Product Type
Table 9. List of Tier 1 Antisense and RNAi Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Antisense and RNAi Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - China Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Antisense and RNAi Therapeutics Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Antisense and RNAi Therapeutics Revenue (US$, Mn), 2022-2027
Table 14. By Application - China Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Antisense and RNAi Therapeutics Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Antisense and RNAi Therapeutics Revenue (US$, Mn), 2022-2027
Table 17. Tekmira Pharmaceuticals Company Details
Table 18. Tekmira Pharmaceuticals Business Overview
Table 19. Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Product
Table 20. Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Tekmira Pharmaceuticals Recent Developments
Table 22. Arbutus Biopharma Company Details
Table 23. Arbutus Biopharma Business Overview
Table 24. Arbutus Biopharma Antisense and RNAi Therapeutics Product
Table 25. Arbutus Biopharma Antisense and RNAi Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 26. Arbutus Biopharma Recent Developments
Table 27. Alnylam Pharmaceuticals Company Details
Table 28. Alnylam Pharmaceuticals Business Overview
Table 29. Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Product
Table 30. Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 31. Alnylam Pharmaceuticals Recent Developments
Table 32. Antisense Therapeutics Company Details
Table 33. Antisense Therapeutics Business Overview
Table 34. Antisense Therapeutics Antisense and RNAi Therapeutics Product
Table 35. Antisense Therapeutics Antisense and RNAi Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 36. Antisense Therapeutics Recent Developments
Table 37. Silence Therapeutics Company Details
Table 38. Silence Therapeutics Business Overview
Table 39. Silence Therapeutics Antisense and RNAi Therapeutics Product
Table 40. Silence Therapeutics Antisense and RNAi Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 41. Silence Therapeutics Recent Developments
Table 42. Isis Pharmaceuticals Company Details
Table 43. Isis Pharmaceuticals Business Overview
Table 44. Isis Pharmaceuticals Antisense and RNAi Therapeutics Product
Table 45. Isis Pharmaceuticals Antisense and RNAi Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 46. Isis Pharmaceuticals Recent Developments
Table 47. Sirnaomics Company Details
Table 48. Sirnaomics Business Overview
Table 49. Sirnaomics Antisense and RNAi Therapeutics Product
Table 50. Sirnaomics Antisense and RNAi Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 51. Sirnaomics Recent Developments
Table 52. Santaris Company Details
Table 53. Santaris Business Overview
Table 54. Santaris Antisense and RNAi Therapeutics Product
Table 55. Santaris Antisense and RNAi Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 56. Santaris Recent Developments
Table 57. Roche Company Details
Table 58. Roche Business Overview
Table 59. Roche Antisense and RNAi Therapeutics Product
Table 60. Roche Antisense and RNAi Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 61. Roche Recent Developments
List of FiguresFigure 1. Antisense and RNAi Therapeutics Segment by Type
Figure 2. Antisense and RNAi Therapeutics Segment by Application
Figure 3. China Antisense and RNAi Therapeutics Market Overview: 2020
Figure 4. China Antisense and RNAi Therapeutics Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Antisense and RNAi Therapeutics Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Antisense and RNAi Therapeutics Revenue in 2020
Figure 7. By Type - China Antisense and RNAi Therapeutics Revenue Market Share, 2016-2027
Figure 8. By Application - China Antisense and RNAi Therapeutics Revenue Market Share, 2016-2027
Figure 9. Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Arbutus Biopharma Antisense and RNAi Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Antisense Therapeutics Antisense and RNAi Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Silence Therapeutics Antisense and RNAi Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Isis Pharmaceuticals Antisense and RNAi Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Sirnaomics Antisense and RNAi Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Santaris Antisense and RNAi Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Roche Antisense and RNAi Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)